Due to the global COVID-19 pandemic and its extensive worldwide impact, the EBMT Board made the decision to hold the 47th EBMT Annual Meeting (EBMT 2021) as a virtual edition.
The EBMT is honoured to invite you to the 47th EBMT Annual Meeting, which will take place virtually, 14th-17th March, 2021.
More than 6,700 delegates attend the EBMT Annual Meeting. Our top-notch scientific programme for physicians, nurses, data and quality managers, pharmacists, psychologists, transplant coordinators, and other medical professionals continues to evolve and develop, with additional new topics added every year.
The EBMT 2021 Scientific Programme will offer a great selection of symposia and educational sessions related to the current challenges of haematopoietic stem cell transplantation (HSCT) and cell therapy.
We look forward to welcoming you to the 47th Annual Meeting of the EBMT, and the second fully virtual edition at EBMT 2021!
Rafael F. Duarte – Congress President
Anna Sureda – Scientific Chair
Julia Ruiz-Pato and Isabel Salcedo – Local Nurses Chair
Michelle Kenyon – President Elect of the Nurses Group
John Murray – President of the Nurses Group
Nicolaus Kröger – EBMT President
|13 December, 2020||Physicians, Nurses, Data Management, Statistics, Quality Management’s abstract submission deadline|
|14 March, 2021||First day of the Virtual Annual Meeting|
|17 March, 2021||Last day of the Virtual Annual Meeting|
Check the scientific programme
The EBMT scientific council, together with the local organising committee, has designed an outstanding programme to cover key issues relating to HSCT and cellular therapy research.
Sponsorship & Exhibition
Companies involved in the HSCT field are invited to support the EBMT2021 Annual Meeting. We have a variety of opportunities available for those interested in sponsorship or exhibition.
Meet the EBMT Young Ambassadors 2021
Eight physicians and nurses have been selected as the EBMT Young Ambassadors 2021, based on academic credentials, achievements and passion for advancing the field of HSCT and Cellular Therapy.